![](https://1etx.com/wp-content/uploads/2022/10/top-e1666540235434.jpg)
The future of therapeutic
RNA silencing
1E Therapeutics is a breakthrough drug development company,
creating a novel class of programmable oligonucleotide therapeutics,
designed to treat humanity’s most intractable diseases by autonomously and precisely
silencing disease-causing RNAs in human or pathogen cells
![](https://1etx.com/wp-content/uploads/2022/10/biology-scaled.jpg)
Unique biology.
Differentiated by design.
1E's groundbreaking, patented platform is uniquely able to create safer and more targeted therapies that address chronic and life-threatening indications as well as emerging and evolving pathogens
A single platform addressing a wide array of indications
![](https://1etx.com/wp-content/uploads/2022/10/platform_1.png)
Genetically driven diseases
Cancer, ALS, Huntington’s
disease, Angelman syndrome
disease, Angelman syndrome
![](https://1etx.com/wp-content/uploads/2022/10/platform_2.png)
Infectious diseases
Multidrug resistant bacteria
(e.g., MRSA, Pseudomonas,
Klebsiella), RSV
(e.g., MRSA, Pseudomonas,
Klebsiella), RSV
![](https://1etx.com/wp-content/uploads/2022/10/platform_3.png)
Chronic diseases
CNS disorders, age-related
disorders, metabolic diseases
disorders, metabolic diseases
![](https://1etx.com/wp-content/uploads/2022/10/contact-scaled-e1666541143756.jpg)